- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07827703
Effects of Digital Detox on Mental Health in Young Adults
Effects of Digital Detox on Mental Health in Young Adults: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether a short, self-guided program for cutting down smartphone screen time can reduce symptoms of depression in young adults. It includes students in Oslo, Norway, who have applied for help at the student mental health service (SiO Mental Health).
The main questions it aims to answer are:
- Does a 2-week screen time reduction program reduce symptoms of depression?
- Does it reduce symptoms of anxiety?
- Can a simple, widely available phone app reduce screen time, and does the reduction last?
Researchers will compare students who start the program right away with students who continue their usual care for 2 weeks and receive the same program afterwards. Participants are placed in one of the two groups by chance, like flipping a coin.
Participants will:
- Answer questionnaires about depression and anxiety symptoms at the start and again after 2 weeks
- Upload screenshots of the Screen Time summary on their iPhone at the start, after 2 weeks, and after 12 weeks
- Install an app that blocks the apps they find most distracting and keep it active for 2 weeks, if they are placed in the program group
- Take part entirely online, with no clinic visits and no contact with the study team
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Thomas Mildestvedt, Professor
- Telefonnummer: +47 55586163
- E-Mail: thomas.mildestvedt@uib.no
Studienorte
-
-
-
Oslo, Norwegen
- Studentsamskipnaden i Oslo
-
Kontakt:
- Thomas Mildestvedt, Professor
- Telefonnummer: +47 55586163
- E-Mail: thomas.mildestvedt@uib.no
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Has applied for care at SiO Mental Health, the student mental health service in Oslo, and has received the service's response to the application
- Owns an iPhone (the screen time restriction tool requires iOS)
- Able to understand written Norwegian
- Provides informed consent
Exclusion Criteria:
- None
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Kein Eingriff: Pflege wie gewohnt
|
|
|
Experimental: Screen time reduction
|
Two-week self-guided use of an iOS screen time restriction app. Participants block their most distracting apps, with notifications disabled. Unlocking requires a 30-second delay, allows 10 minutes of access, then a 5-minute cooldown. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Symptoms of depression (PHQ-9)
Zeitfenster: From enrollment to the end of intervention at 2 weeks
|
Patient Health Questionnaire-9, range 0 to 27, higher scores indicate more depressive symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Total smartphone screen time
Zeitfenster: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Smartphone screen time by app category
Zeitfenster: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Number of daily smartphone pickups
Zeitfenster: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Symptoms of anxiety (GAD-7)
Zeitfenster: From enrollment to the end of intervention at 2 weeks
|
Generalized Anxiety Disorder-7, range 0 to 21, higher scores indicate more anxiety symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Self-reported changes in daily functioning and well-being
Zeitfenster: 2 weeks
|
Twelve single-item questions on perceived change over the past 2 weeks, each answered on a 5-point scale from 1 (much less than usual) to 5 (much more than usual). The domains are sleep, time spent with others, physical activity, time on other screens (computer, tablet), loneliness, satisfaction with oneself, rumination on negative thoughts, feeling of missing out, stress, ability to concentrate, satisfaction with own study effort, and getting done what one plans. Higher scores indicate more of the attribute than usual. Whether a higher score represents a better outcome depends on the domain. |
2 weeks
|
|
Adherence to the screen time restriction tool
Zeitfenster: 2 weeks
|
Self-reported proportion of the 2-week period with the blocking rule kept active, answered on a 5-level ordinal scale: all of the time, most of the time, part of the time, little of the time, none. Higher levels indicate greater adherence. Reported by the intervention group. |
2 weeks
|
|
Perceived usefulness and burden of the tool
Zeitfenster: 2 weeks and 12 weeks
|
Perceived usefulness of the tool for reducing screen time and perceived burden in everyday life, each answered on a 5-point scale from 1 (not at all) to 5 (to a very great extent), and a single question on intention to continue use (yes, no, do not know). Higher usefulness indicates a better outcome and higher burden a worse outcome. Reported by the intervention group at 2 weeks and by both groups at 12 weeks. |
2 weeks and 12 weeks
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Thomas Mildestvedt, Professor, University of Bergen
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 1000700
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Anonymized individual participant data underlying the published results.
IPD-Sharing-Zeitrahmen
After publication of the primary results.
IPD-Sharing-Zugriffskriterien
Upon request to the principal investigator, under a data sharing agreement.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
- ICF
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .